Markt geschlossen -
Andere Börsenplätze
|
% 5 Tage | % 1. Jan. | ||
686 INR | -0,02 % | +0,19 % | +25,70 % |
25.04. | Kanadische Produktionseinheit der Jubilant Pharmova-Tochtergesellschaft erhält fünf Anmerkungen von der US FDA | MT |
02.02. | Indisches Unternehmen Jubilant Pharmova mit Quartalsgewinn | RE |
Kurzporträt
Mitarbeiterzahl: 5 778
Umsatz nach Geschäftsbereich
INR in Millionen | 2022 | Gewichtung | 2023 | Gewichtung | Delta |
---|---|---|---|---|---|
Radiopharma
40,6
%
| - | - | 25 524 | 40,6 % | - |
Contract Research, and Development and Manufacturing Organisation
18,9
%
| - | - | 11 847 | 18,9 % | - |
Contract Development and Manufacturing Organisation - Sterile Injecttables
18,4
%
| - | - | 11 547 | 18,4 % | - |
Generics
12,1
%
| - | - | 7 615 | 12,1 % | - |
Allergy Immunotherapy
9,6
%
| - | - | 6 028 | 9,6 % | - |
Management Services
0,3
%
| 202 | 0,3 % | 218 | 0,3 % | +7,69 % |
Proprietary Novel Drugs
0,1
%
| 18 | 0,0 % | 38 | 0,1 % | +107,39 % |
Umsatz je Region
INR in Millionen | 2022 | Gewichtung | 2023 | Gewichtung | Delta |
---|---|---|---|---|---|
Americas and Europe
89,0
%
| 53 194 | 86,8 % | 55 935 | 89,0 % | +5,15 % |
Rest of the World
7,9
%
| 4 587 | 7,5 % | 4 976 | 7,9 % | +8,47 % |
India
3,0
%
| 3 394 | 5,5 % | 1 907 | 3,0 % | -43,83 % |
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
Chief Executive Officer | 46 | 23.05.17 | |
Chief Executive Officer | 37 | 23.05.17 | |
Arvind Chokhany
DFI | Director of Finance/CFO | 52 | 01.04.21 |
Chairman | 71 | 20.06.78 | |
Chairman | 67 | 01.01.82 | |
Chief Tech/Sci/R&D Officer | 46 | 04.05.22 | |
Naresh Kapoor
CMP | Compliance Officer | - | 01.08.22 |
Ajay Khanna
IRO | Public Communications Contact | 63 | 01.06.09 |
Shantanu Jha
HRO | Human Resources Officer | - | - |
Tushar Gupta
PRN | Corporate Officer/Principal | - | 25.10.21 |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Chairman | 67 | 01.01.82 | |
Chairman | 71 | 20.06.78 | |
Chief Executive Officer | 46 | 23.05.17 | |
Arun Seth
BRD | Director/Board Member | 72 | 22.10.18 |
Vivek Mehra
BRD | Director/Board Member | 69 | 23.05.17 |
Chief Executive Officer | 37 | 23.05.17 | |
Director/Board Member | 69 | 07.03.23 | |
Arvind Chokhany
DFI | Director of Finance/CFO | 52 | 01.04.21 |
R. Kumar
BRD | Director/Board Member | 60 | 01.07.22 |
Director/Board Member | 43 | 01.11. |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 159 282 631 | 57 860 674 ( 36,33 %) | 931 894 ( 0,5851 %) | 36,33 % |
Unternehmensbesitz
Name | Aktien | % | Bewertung |
---|---|---|---|
50 000 | 0,33% | 697 821 $ |
Unternehmenskontakt
Konzerngesellschaften
Name | Kategorie und Branche |
---|---|
PSI Supply NV
PSI Supply NV Drugstore ChainsRetail Trade PSI Supply NV is a Belgian company that supplies and distributes pharmaceutical products. The private company is based in Ghent, Belgium. |
Drugstore Chains
|
Jubilant Biosys Ltd.
Jubilant Biosys Ltd. Pharmaceuticals: MajorHealth Technology Jubilant Biosys Ltd. specializes in drug discovery services, proprietary in-house innovation, and strategic investments. Its services include discovery informatics, computational chemistry, structural biology, chemistry, in vitro and in vivo biology, and toxicology. The company was founded by VN Balaji in 2001 and is headquartered in Noida, India. |
Pharmaceuticals: Major
|
Jubilant Pharma NV
Jubilant Pharma NV Pharmaceuticals: MajorHealth Technology Part of Jubilant Industries Ltd., Jubilant Pharma NV is a Belgian pharmaceutical company. The private company is based in Merelbeke, Belgium. Founded in 2004, Jubilant Pharma operates in the pharmaceutical industry. |
Pharmaceuticals: Major
|
Jubilant Pharmaceuticals NV
| |
Jubilant Pharma Ltd.
Jubilant Pharma Ltd. Pharmaceuticals: MajorHealth Technology Jubilant Pharma Ltd. manufactures pharmaceutical products. Its products include solid dosage formulations, radiopharmaceuticals and allergy therapy products. The firm provides contract manufacturing services. The company is headquartered in Singapore. |
Pharmaceuticals: Major
|
Jubilant Clinsys, Inc.
Jubilant Clinsys, Inc. Miscellaneous Commercial ServicesCommercial Services Jubilant Clinsys, Inc. offers global clinical trials support operations, clinical development, and phase i-iv clinical trials. The company is headquartered in Yardley, NJ. |
Miscellaneous Commercial Services
|
Jubilant Generics Ltd.
Jubilant Generics Ltd. Pharmaceuticals: MajorHealth Technology Jubilant Generics Ltd. engages in the manufacture and export of pharmaceutical products. The company is headquartered in Greater Noida, India. |
Pharmaceuticals: Major
|
TrialStat Solutions, Inc.
| |
Jubilant Pharma Holdings, Inc.
|
Sektor
Umsatz nach Geschäftsbereich
Umsatz je Region
% 1. Jan. | Kap. | |
---|---|---|
+25,70 % | 1,3 Mrd. | |
+26,47 % | 661 Mrd. | |
+26,74 % | 566 Mrd. | |
-6,33 % | 352 Mrd. | |
+19,35 % | 332 Mrd. | |
+4,23 % | 283 Mrd. | |
+13,43 % | 231 Mrd. | |
+4,71 % | 200 Mrd. | |
-9,53 % | 195 Mrd. | |
-4,04 % | 145 Mrd. |
- Börse
- Aktien
- A0J2PQ Aktie
- Unternehmen Jubilant Pharmova Limited